These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 18653582

  • 1. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice.
    Elliott P, Spirito P.
    Heart; 2008 Oct; 94(10):1269-75. PubMed ID: 18653582
    [Abstract] [Full Text] [Related]

  • 2. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 3. Hypertrophic cardiomyopathy: lessons from history.
    Coats CJ, Hollman A.
    Heart; 2008 Oct; 94(10):1258-63. PubMed ID: 18653579
    [Abstract] [Full Text] [Related]

  • 4. [Cardiomyopathies. VIII. Sudden death in hypertrophic cardiomyopathy].
    Alfonso F.
    Rev Esp Cardiol; 1996 Apr; 49(4):288-304. PubMed ID: 8650406
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

  • 6. Risk assessment in hypertrophic cardiomyopathy.
    Ward D.
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218266
    [No Abstract] [Full Text] [Related]

  • 7. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ, Estes NA, Maron MS, Almquist AK, Link MS, Udelson JE.
    Circulation; 2003 Jun 17; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract] [Full Text] [Related]

  • 8. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ.
    Eur Heart J; 2009 Jul 17; 30(13):1627-34. PubMed ID: 19406869
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ, Towbin JA, Denfield SW.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):250-4. PubMed ID: 19589438
    [Abstract] [Full Text] [Related]

  • 10. [Hypertrophic cardiomyopathy and sudden death].
    Piccininno M, Spirito P.
    Recenti Prog Med; 2001 Mar 14; 92(3):205-8. PubMed ID: 11320853
    [Abstract] [Full Text] [Related]

  • 11. Sudden cardiac death due to hypertrophic cardiomyopathy can be reduced by pre-participation cardiovascular screening in young athletes.
    Panhuyzen-Goedkoop NM, Verheugt FW.
    Eur Heart J; 2006 Sep 14; 27(18):2152-3. PubMed ID: 16877480
    [No Abstract] [Full Text] [Related]

  • 12. Cardiac diseases of young people. II: Hypertrophic cardiomyopathy.
    Cowley ML.
    J R Nav Med Serv; 1995 Sep 14; 81(1):26-32. PubMed ID: 7562702
    [Abstract] [Full Text] [Related]

  • 13. Hypertrophic cardiomyopathy and sudden cardiac death due to physical exercise in Croatia in a 27-year period.
    Duraković Z, Duraković MM, Skavić J.
    Coll Antropol; 2011 Dec 14; 35(4):1051-4. PubMed ID: 22397237
    [Abstract] [Full Text] [Related]

  • 14. Hypertrophic cardiomyopathy.
    Ommen SR, Nishimura RA.
    Curr Probl Cardiol; 2004 May 14; 29(5):239-91. PubMed ID: 15123994
    [Abstract] [Full Text] [Related]

  • 15. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA, Gomes JA, Fuster V.
    Nat Clin Pract Cardiovasc Med; 2007 Dec 14; 4(12):667-76. PubMed ID: 18033231
    [Abstract] [Full Text] [Related]

  • 16. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S, Spirito P, Masi AS, Chiribiri A, Bonamini R, Conte MR.
    Circ Cardiovasc Imaging; 2009 Jul 14; 2(4):349-50. PubMed ID: 19808616
    [No Abstract] [Full Text] [Related]

  • 17. The athlete's heart: prevention of sudden cardiac death.
    Manshadi R.
    Rev Cardiovasc Med; 2008 Jul 14; 9(4):259-60. PubMed ID: 19122583
    [No Abstract] [Full Text] [Related]

  • 18. Hypertrophic cardiomyopathy: ask athletes these 9 questions.
    deWeber K, Beutler A.
    J Fam Pract; 2009 Nov 14; 58(11):576-84. PubMed ID: 19891935
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ.
    Rev Esp Cardiol; 2006 Jun 14; 59(6):527-30. PubMed ID: 16790193
    [No Abstract] [Full Text] [Related]

  • 20. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
    Efthimiadis GK, Parcharidou DG, Giannakoulas G, Pagourelias ED, Charalampidis P, Savvopoulos G, Ziakas A, Karvounis H, Styliadis IH, Parcharidis GE.
    Am J Cardiol; 2009 Sep 01; 104(5):695-9. PubMed ID: 19699347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.